Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Director/PDMR Shareholding

31 Mar 2023 15:47

RNS Number : 0078V
Pod Point Group Holdings PLC
31 March 2023
 

31 March 2023

 

Pod Point Group Holdings plc

(the "Company" or "Pod Point")

Notification of Transactions by Persons Discharging Managerial Responsibilities ('PDMRs')

 

The Company announces that, on 31 March 2023, it granted Nil Cost Options ("Options") over Ordinary Shares of £0.001 each in the Company ("Shares"), in accordance with the Rules of the Pod Point Deferred Bonus Share Plan ("DBSP"), to the Executive Directors of the Company.

 

In accordance with the Remuneration Policy, up to 30% of the outturn of the Annual Bonus Plan is deferred into Shares. These awards relate to the deferral of 30% of the annual bonus earned by the Executive Directors in respect of the financial year ended 31 December 2022. The Options, which will vest on the second anniversary of the grant, are not subject to further performance conditions but are subject to continued employment in accordance with the rules of the DBSP.

 

No consideration is payable either on the grant or vesting of the Options.

 

Oare subject to malus and clawback provisions.

 

This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

 

1.

Details of the PDMR

a)

Name

Erik Fairbairn

2.

Reason for notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pod Point Group Holdings plc

b)

LEI

213800MY9U5MEDG21D89

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary shares of £0.001 each

 

 

ISIN: GB00BNDRD100

b)

Nature of the transaction

Grant of Nil Cost Option under the Deferred Share Bonus Plan

c)

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

£0.00

96,540

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

N/A

 

e)

Date of the transaction

31 March 2023

 

f)

Place of the transaction

Outside of a trading venue

 

 

 

1.

Details of the PDMR

c)

Name

David Wolffe

2.

Reason for notification

d)

Position / status

Chief Financial Officer

e)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pod Point Group Holdings plc

b)

LEI

213800MY9U5MEDG21D89

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

g)

Description of the financial instrument

Identification code

Ordinary shares of £0.001 each

ISIN: GB00BNDRD100

h)

Nature of the transaction

Grant of Nil Cost Option under the Deferred Share Bonus Plan

i)

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

£0.00

33,218

j)

Aggregated information

 

Aggregated volume

 

Price

 

 

N/A

 

k)

Date of the transaction

31 March 2023

 

l)

Place of the transaction

Outside of a trading venue

 

Anita Guernari

Company Secretary

 

Enquiries

Teneo(Public relations advisor to Pod Point)

+44 207 353 4200

85fs.podpoint@teneo.com

Mark Burgess, Matt Low, Arthur Rogers

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDXLSXDGXB
Date   Source Headline
27th Sep 20224:36 pmRNSPrice Monitoring Extension
2nd Sep 20227:00 amRNSExercise of Options and Issue of New Shares
16th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
30th Jun 20227:00 amRNSCFO Designate Appointment
10th Jun 20223:00 pmRNSSecond Manufacturer Contract
8th Jun 20226:30 pmRNSBlock listing Interim Review
27th May 20224:36 pmRNSPrice Monitoring Extension
9th May 20225:45 pmRNSPublication of Annual Financial Report (updated)
9th May 20224:43 pmRNSPublication of Annual Financial Report
4th May 20222:28 pmRNSDirector Declaration
11th Apr 202212:05 pmRNSNew Contract Win
14th Mar 20224:30 pmRNSDirector/PDMR Shareholding
11th Mar 20225:25 pmRNSDirector Declaration
21st Feb 20229:00 amRNSEstablishment of new ESG Committee
18th Feb 20227:00 amRNSPreliminary Unaudited Results for FY2021
6th Jan 20227:00 amRNSTrading Update and Notice of Results
4th Jan 202211:00 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSDirector Declaration
20th Dec 20214:00 pmRNSAppointment of Joint Corporate Brokers
3rd Dec 20216:33 pmRNSExercise of Over-allotment Option
3rd Dec 20214:57 pmRNSPost-Stabilisation Period Announcement
3rd Dec 20212:15 pmRNSBlock Listing Application
1st Dec 202110:06 amRNSTotal Voting Rights
25th Nov 20214:13 pmRNSNew Contract Win
16th Nov 202111:57 amRNSHolding(s) in Company - Replacement
12th Nov 20217:00 amRNSMid-stabilisation Period Announcement
11th Nov 20214:38 pmRNSHolding(s) in Company
9th Nov 20217:21 amRNSAdmission to Trading on the London Stock Exchange
4th Nov 20211:51 pmRNSApproval and Publication of Prospectus
4th Nov 20217:00 amRNSPre-Stabilisation Period Notice
4th Nov 20217:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.